VE against clinical malaria in infants was 27 % ( 95 % CI 20 % to 32 % , per protocol ; 27 % [ 95 % CI 21 % to 33 % ] , ITT ) , with no significant protection against severe malaria , malaria hospitalization , or all-cause hospitalization .